New Anthrax Therapy Plays Dual Role

by Medindia Content Team on October 17, 2007 at 3:59 PM
New Anthrax Therapy Plays Dual Role

US researchers from the Scripps Research Institute and The Salk Institute for Biological Studies have produced a virus-like particle that prevents infection against a dose of anthrax that would normally prove lethal. In experiments with rats, the scientists found that the vaccine, based on the Flock House insect virus, was able to prevent infection after just one dose.

The vaccine caused the animals' immune system to produce antibodies that later protected them by mopping up anthrax toxin elsewhere. The scientists say this is a step better than a two-dose nasal vaccine previously developed. The therapy acts both as a vaccine and a treatment.


Studies further proved that in addition to protecting the rats against anthrax infection, the virus also proved effective in treating rats already infected with a potentially deadly dose. In this role, the unfilled receptors on the surface of the virus snatched toxin molecules before they could do too much damage. While all the treated animals survived, none of the untreated animals did.

The researchers speculate the particle's ability to display multiple copies of toxin receptors explains its potency. Vaccines currently in use require up to six doses to be administered, together with annual boosters. This complicated dosing procedure means full compliance is often poor, and increases the risks for those who require protection in difficult situations such as in conflict zones.

For people already infected, antibiotic treatment is effective - but only if given quickly enough. The researchers say the treatment might eventually be used in combination with antibiotics. "This recombinant virus-like particle represents a novel and highly effective, dually-acting reagent for treatment and protection against anthrax," said team leader Anette Schneemann of The Scripps Research Institute.

"Clearly the US Government is keen to find a vaccine that requires fewer doses to boost compliance. One that acts as a medication could also be very useful. We'll need larger scale studies, though, to see how useful this new treatment actually is," said Phil Luton, an anthrax expert at the UK's Health Protection Agency site in Porton Down.

The study appears in the journal PLoS Pathogens, reports New Scientist magazine.

Source: ANI
Font : A-A+



Latest General Health News

Brain Care Score Tracks Dementia & Stroke Risks
The Brain Care Score is a tool to evaluate brain health and reduce the risk of brain disorders including dementia and stroke.
First Human Case of Rare Swine Flu Strain H1N2 Found in UK
Swine influenza A viruses, including subtypes H1N1, H1N2, and H3N2, are prominent among pigs and sporadically transmit to humans.
Unraveling the Mystery Respiratory Illness in US Dogs
The microorganism "is a newly identified potential disease-causing agent, possibly originating from or evolving within the dog's microbiome."
Why Red Wine Cause Headache?
Flavanol naturally present in red wine can compromise the proper metabolism of alcohol and lead to a headache.
Raw Meat Raises Antibiotic-Resistant E.Coli Risk in Dogs
To reduce bacterial risks, pet owners can switch to a non-raw diet or obtain quality raw meat for cooking before feeding dogs.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

New Anthrax Therapy Plays Dual Role Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests